Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Ischemic Heart Disease

  Free Subscription


6 Am Heart J
4 Am J Cardiol
2 Am J Emerg Med
2 Am J Med
3 Ann Thorac Surg
4 Arterioscler Thromb Vasc Biol
44 Catheter Cardiovasc Interv
1 Circ Cardiovasc Interv
1 Circ Cardiovasc Qual Outcomes
6 Circ J
1 Circ Res
1 Circulation
8 Eur Heart J
1 Hypertension
5 Int J Cardiol
6 J Am Coll Cardiol
6 J Cardiovasc Pharmacol
1 J Clin Endocrinol Metab
1 J Clin Epidemiol
1 J Mol Cell Cardiol
1 Lancet
2 N Engl J Med
1 Psychosom Med

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. BAGIELLA E, Puskas JD, Moskowitz AJ, Gelijns AC, et al
    Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts.
    Am Heart J. 2022;246:12-20.
    PubMed         Abstract available

  2. HARA H, Serruys PW, O'Leary N, Gao C, et al
    Angiography-derived physiology guidance versus usual care in an All-comers PCI population treated with the Healing-Targeted Supreme stent and Ticagrelor monotherapy: PIONEER IV trial design.
    Am Heart J. 2022 Jan 3. pii: S0002-8703(21)00500.
    PubMed         Abstract available

  3. BURSTEIN B, Anand V, Ternus B, Tabi M, et al
    Noninvasive Echocardiographic Cardiac Power Output Predicts Mortality in Cardiac Intensive Care Unit Patients.
    Am Heart J. 2021 Dec 22. pii: S0002-8703(21)00479.
    PubMed         Abstract available

  4. NANNA MG, Vemulapalli S, Fordyce CB, Mark DB, et al
    The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial.
    Am Heart J. 2022;245:136-148.
    PubMed         Abstract available

  5. HORNE BD, Muhlestein JB, Lappe DL, May HT, et al
    Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial.
    Am Heart J. 2022;244:125-134.
    PubMed         Abstract available

  6. BAINEY KR, Fleg JL, Hochman JS, Kunichoff DF, et al
    Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia.
    Am Heart J. 2022;243:187-200.
    PubMed         Abstract available

    Am J Cardiol

  7. HACHIYA S, Kosuge H, Fujita Y, Hida S, et al
    Performance of Hybrid Imaging in the Diagnosis of Coronary Artery Disease.
    Am J Cardiol. 2022 Apr 1. pii: S0002-9149(22)00236.
    PubMed         Abstract available

  8. KUMAR K, Chau T, Herman T, Samhan A, et al
    Transcatheter Aortic Valve Implantation in Patients With Previous Coronary Artery Bypass Grafting.
    Am J Cardiol. 2022 Apr 2. pii: S0002-9149(22)00258.

  9. CHEW NWS, Ng CH, Kong G, Lee KS, et al
    Meta-Analysis of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Narrowing.
    Am J Cardiol. 2022 Apr 4. pii: S0002-9149(22)00238.
    PubMed         Abstract available

  10. LEVI N, Dadon Z, Steinmetz Y, Perel N, et al
    Prevalence, Predictors, and Outcomes of Patients With ST-Elevation Myocardial Infarction and Angiographically Significant Coronary Artery Disease of Non-Infarct-Related Artery.
    Am J Cardiol. 2022 Mar 31. pii: S0002-9149(22)00235.
    PubMed         Abstract available

    Am J Emerg Med

  11. SUPPLES MW, Vaizer J, Liao M, Faris GW, et al
    Increased weight in patients with time-sensitive diagnosis is associated with longer prehospital on-scene times.
    Am J Emerg Med. 2022;53:236-239.
    PubMed         Abstract available

  12. CHOI Y, Lee JH
    Dynamic changes in electrocardiographic findings between initial and follow-up electrocardiography: The role of the T/QRS ratio.
    Am J Emerg Med. 2022;54:8-14.
    PubMed         Abstract available

    Am J Med

    Cardiorespiratory Fitness and Atherosclerotic Cardiovascular Outcomes: How Can We Apply the Look AHEAD Study to Daily Practice?
    Am J Med. 2022;135:e93.

  14. HIRSCH E, Qunaj L, Latib A, Galen B, et al
    Polycythemia Vera Presenting as ST-Segment Elevation Myocardial Infarction.
    Am J Med. 2022 Mar 31. pii: S0002-9343(22)00251.

    Ann Thorac Surg

  15. FATTOUCH K, Dioguardi P, Guccione F, Nogara A, et al
    10-Year Results of Mitral Repair and Coronary Bypass for Ischemic Regurgitation: A Randomized Trial.
    Ann Thorac Surg. 2022;113:816-822.
    PubMed         Abstract available

  16. ARAI Y, Asai H, Ebuoka N, Oba J, et al
    Tubular pouch technique using aortic tissues for single coronary artery transfer.
    Ann Thorac Surg. 2022 Apr 1. pii: S0003-4975(22)00473.
    PubMed         Abstract available

  17. SUN SB, Fan G, Farhaj Z, Hongxin L, et al
    A giant cardiac hemangioma encroaching the right coronary artery.
    Ann Thorac Surg. 2022 Mar 31. pii: S0003-4975(22)00470.
    PubMed         Abstract available

    Arterioscler Thromb Vasc Biol

  18. GUPTA RM
    Causal Gene Confusion: The Complicated EDN1/PHACTR1 Locus for Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2022 Apr 7:101161ATVBAHA122317539.

  19. JARR KU, Kojima Y, Weissman IL, Leeper NJ, et al
    2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis.
    Arterioscler Thromb Vasc Biol. 2022 Apr 7:101161ATVBAHA122317049.
    PubMed         Abstract available

  20. GAO JW, You S, Liu ZY, Hao QY, et al
    Different Metabolic Phenotypes of Obesity and Risk of Coronary Artery Calcium Progression and Incident Cardiovascular Disease Events: The CARDIA Study.
    Arterioscler Thromb Vasc Biol. 2022 Apr 7:ATVBAHA122317526.
    PubMed         Abstract available

  21. TAM CF, Chan YH, Wong YK, Li Z, et al
    Multi-Omics Signatures Link to Ticagrelor Effects on Vascular Function in Patients With Acute Coronary Syndrome.
    Arterioscler Thromb Vasc Biol. 2022 Apr 7:101161ATVBAHA121317513.
    PubMed         Abstract available

    Catheter Cardiovasc Interv

  22. HERNANDEZ-SUAREZ DF, Azzalini L, Moroni F, Tinoco de Paula JE, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.
    Catheter Cardiovasc Interv. 2021 Dec 20. doi: 10.1002/ccd.30041.
    PubMed         Abstract available

  23. GARBO R, Di Russo C, Sciahbasi A, Fedele S, et al
    The last resort during complex retrograde percutaneous coronary chronic total occlusion intervention: Extraplaque intracoronary lithotripsy to externally crush a heavy calcified occluded stent.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30050.
    PubMed         Abstract available

  24. LOW RJB, Khoo DZL, Ong PJL
    Case report: A novel application of the MicroVascular Plug (MVP) in treating distal coronary perforation.
    Catheter Cardiovasc Interv. 2022;99:502-507.
    PubMed         Abstract available

  25. SHAMKHANI W, Kinnaird T, Ludman P, Rashid M, et al
    Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30081.
    PubMed         Abstract available

  26. MARCHESE N, Barbato E, Di Gioia G, Stanislao M, et al
    Intracoronary pressures to predict myocardial viability in patients with ischemic left ventricular dysfunction.
    Catheter Cardiovasc Interv. 2022;99:271-279.
    PubMed         Abstract available

  27. GOLDSTEIN JA, Mehta NK
    Extent of coronary atherosclerosis and ischemic myocardium foment sudden cardiac death.
    Catheter Cardiovasc Interv. 2022;99:812-813.

  28. TARANTINI G, Cardaioli F
    Coronary complete revascularization strategy: A puzzle still hard to complete.
    Catheter Cardiovasc Interv. 2022;99:639-640.

    Sound and light editorial: The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2022;99:674-675.

  30. KHAN AA, Dangas G
    Is cardiac surgery backup required for left main stenting?
    Catheter Cardiovasc Interv. 2022;99:607-608.

  31. WIEBE J, Hofmann FJ, West N, Baumbach A, et al
    Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium.
    Catheter Cardiovasc Interv. 2022;99:533-540.
    PubMed         Abstract available

  32. SHOAIB A, Spratt JC, Curzen N, Wilson S, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.
    Catheter Cardiovasc Interv. 2021 Nov 19. doi: 10.1002/ccd.30015.
    PubMed         Abstract available

  33. AKL E, Pinilla-Echeverri N, Garcia-Garcia HM, Mehta SR, et al
    First in-human evaluation of a novel intravascular ultrasound and optical coherence tomography system for intracoronary imaging.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30001.
    PubMed         Abstract available

  34. KANDZARI DE, Kirtane AJ, Mehran R, Price MJ, et al
    Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
    Catheter Cardiovasc Interv. 2022;99:583-592.
    PubMed         Abstract available

  35. CUENIN L, Honton B, Aminfar F, Meyer P, et al
    Head to head comparison of quantitative flow ratio using 4-French and 6-French catheters versus fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;99:746-753.
    PubMed         Abstract available

  36. KANDZARI DE, Alaswad K, Jaffer FA, Brilakis E, et al
    Safety and efficacy of dedicated guidewire, microcatheter, and guide catheter extension technologies for chronic total coronary occlusion revascularization: Primary results of the Teleflex Chronic Total Occlusion Study.
    Catheter Cardiovasc Interv. 2022;99:263-270.
    PubMed         Abstract available

  37. CORTESE B, de la Torre Hernandez JM, Lanocha M, Ielasi A, et al
    Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.
    PubMed         Abstract available

  38. FEENSTRA RGT, van Lavieren MA, Echavarria-Pinto M, Wijntjens GW, et al
    Respiration-related variations in Pd/Pa ratio and fractional flow reserve in resting conditions and during intravenous adenosine administration.
    Catheter Cardiovasc Interv. 2022;99:844-852.
    PubMed         Abstract available

  39. LATIF A, Ahsan MJ, Lateef N, Aurit S, et al
    Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30017.
    PubMed         Abstract available

  40. LEE K, Lee PH, Lee SW, Kwon O, et al
    Primary versus rescue retrograde approach for chronic total coronary occlusion.
    Catheter Cardiovasc Interv. 2022;99:219-225.
    PubMed         Abstract available

  41. XU R, Shi Y, Chang S, Qin Q, et al
    Outcomes of contemporary versus conventional reverse controlled and antegrade and retrograde subintimal tracking in chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2022;99:226-233.
    PubMed         Abstract available

  42. KUFNER S, Rai H, Wiebe J, Altevogt F, et al
    A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (I
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30014.
    PubMed         Abstract available

  43. NOGIC J, Nerlekar N, Soon K, Freeman M, et al
    Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry.
    Catheter Cardiovasc Interv. 2022;99:554-562.
    PubMed         Abstract available

  44. BISWAS S, Dinh D, Duffy SJ, Brennan A, et al
    Characteristics and outcomes of unsuccessful percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29886.
    PubMed         Abstract available

  45. EBERLI FR, Stoll HP, Urban P, Morice MC, et al
    Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study.
    Catheter Cardiovasc Interv. 2022;99:593-600.
    PubMed         Abstract available

  46. VAN HEMERT ND, Rozemeijer R, Voskuil M, Stein M, et al
    Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.
    Catheter Cardiovasc Interv. 2022;99:366-372.
    PubMed         Abstract available

  47. NAKAMURA S, Yonetsu T, Hoshino M, Hada M, et al
    Anatomical-functional discordance between quantitative coronary angiography and diastolic pressure ratio during wave-free period.
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29680.
    PubMed         Abstract available

  48. IQBAL MB, Moore PT, Nadra IJ, Robinson SD, et al
    Complete revascularization in stable multivessel coronary artery disease: A real world analysis from the British Columbia Cardiac Registry.
    Catheter Cardiovasc Interv. 2022;99:627-638.
    PubMed         Abstract available

  49. GONG Y, Zheng B, Yi T, Yang F, et al
    Coronary angiography-derived contrast fractional flow reserve.
    Catheter Cardiovasc Interv. 2021 Feb 15. doi: 10.1002/ccd.29558.
    PubMed         Abstract available

  50. ALAOUR B, Onwordi E, Khan A, Menexi C, et al
    Outcome of left main stem percutaneous coronary intervention in a UK nonsurgical center: A 5-year clinical experience.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29530.
    PubMed         Abstract available

  51. G TOTH G, Ono M, Buschmann E, Wu X, et al
    Usability of Fantom Encore(R) scaffold in non-complex bifurcations-Analysis in bench models.
    Catheter Cardiovasc Interv. 2022;99:424-432.
    PubMed         Abstract available

  52. SAITO Y, Wijns W, Baumbach A, Xu B, et al
    Differential impact of abluminal groove-filled biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent on and off dual antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;99:357-365.
    PubMed         Abstract available

  53. HIRAI T, Grantham JA, Sapontis J, Nicholson WJ, et al
    Development and validation of a prediction model for angiographic perforation during chronic total occlusion percutaneous coronary intervention: OPEN-CLEAN perforation score.
    Catheter Cardiovasc Interv. 2021 Jan 13. doi: 10.1002/ccd.29466.
    PubMed         Abstract available

  54. HIDALGO F, Gonzalez-Manzanares R, Ojeda S, Benito-Gonzalez T, et al
    Instantaneous wave-free ratio for guiding treatment of nonculprit lesions in patients with acute coronary syndrome: A retrospective study.
    Catheter Cardiovasc Interv. 2022;99:489-496.
    PubMed         Abstract available

  55. OSMAN M, Ghaffar YA, Osman K, Kheiri B, et al
    Gender-based outcomes of coronary bifurcation stenting: A report from the National Readmission Database.
    Catheter Cardiovasc Interv. 2022;99:433-439.
    PubMed         Abstract available

  56. JENTZER JC, van Diepen S, Henry TD, Baran DA, et al
    Influence of intra-aortic balloon pump on mortality as a function of cardiogenic shock severity.
    Catheter Cardiovasc Interv. 2021 May 28. doi: 10.1002/ccd.29800.
    PubMed         Abstract available

  57. ERDOGAN E, Huang X, Cooper J, Jain A, et al
    End-diastolic segmentation of intravascular ultrasound images enables more reproducible volumetric analysis of atheroma burden.
    Catheter Cardiovasc Interv. 2021 Aug 17. doi: 10.1002/ccd.29917.
    PubMed         Abstract available

  58. KOSMOPOULOS M, Bartos JA, Raveendran G, Goslar T, et al
    Coronary artery disease burden relation with the presentation of acute cardiac events and ventricular fibrillation.
    Catheter Cardiovasc Interv. 2022;99:804-811.
    PubMed         Abstract available

  59. HUSSAIN Y, Gaston S, Kluger J, Shah T, et al
    Long term outcomes of ultrathin versus standard thickness second-generation drug eluting stents: Meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2022;99:563-574.
    PubMed         Abstract available

  60. G TOTH G, Collet C, Langhoff Thuesen A, Mizukami T, et al
    Influence of fractional flow reserve on grafts patency: Systematic review and patient-level meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:730-735.
    PubMed         Abstract available

  61. MCINERNEY A, Travieso Gonzalez A, Castro Mejia A, Tirado-Conte G, et al
    Long-term outcomes after deferral of revascularization of in-stent restenosis using fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;99:723-729.
    PubMed         Abstract available

  62. HARDING SA, Webber B, Fairley S, Ormiston JA, et al
    Real-time intravascular ultrasound guidance: A novel technique for accurate placement of ostial stents.
    Catheter Cardiovasc Interv. 2022;99:699-705.
    PubMed         Abstract available

  63. HAKEEM A, Hou L, Shah K, Agarwal SK, et al
    Derivation and validation of Pd/Pa in the assessment of residual ischemia post-intervention: A prospective all-comer registry.
    Catheter Cardiovasc Interv. 2022;99:714-722.
    PubMed         Abstract available

  64. KAUL U, Abhyankar A, K Abhaichand R, Bhagwat A, et al
    Serial evaluation of vascular responses after implantation of everolimus-eluting coronary stent by optical coherence tomography.
    Catheter Cardiovasc Interv. 2021 Jun 1. doi: 10.1002/ccd.29794.
    PubMed         Abstract available

  65. SCARSINI R, Terentes-Printzios D, Shanmuganathan M, Kotronias RA, et al
    Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI.
    Catheter Cardiovasc Interv. 2022;99:329-339.
    PubMed         Abstract available

    Circ Cardiovasc Interv

  66. XU J, Lo S, Mussap CJ, French JK, et al
    Impact of Ticagrelor Versus Clopidogrel on Coronary Microvascular Function After Non-ST-Segment-Elevation Acute Coronary Syndrome.
    Circ Cardiovasc Interv. 2022 Apr 4:101161CIRCINTERVENTIONS121011419.
    PubMed         Abstract available

    Circ Cardiovasc Qual Outcomes

  67. LOWENSTERN A, Alexander KP, Pagidipati NJ, Hill CL, et al
    Presenting Symptoms in Patients Undergoing Coronary Artery Disease Evaluation: Association With Noninvasive Test Results and Clinical Outcomes in the PROMISE Trial.
    Circ Cardiovasc Qual Outcomes. 2022 Apr 4:101161CIRCOUTCOMES121008298.
    PubMed         Abstract available

    Circ J

  68. YOSHIOKA G, Sonoda S, Aishima S, Node K, et al
    Multimodality Imaging Approach for a Left Ventricular Aneurysm in a Patient With Myocardial Infarction and Non-Obstructive Coronary Arteries.
    Circ J. 2022 Apr 5. doi: 10.1253/circj.CJ-21-1080.

  69. SAWANO M, Kohsaka S, Ishii H, Numasawa Y, et al
    One-Year Outcome After Percutaneous Coronary Intervention for Acute Coronary Syndrome- An Analysis of 20,042 Patients From a Japanese Nationwide Registry.
    Circ J. 2021;85:1756-1767.
    PubMed         Abstract available

  70. VAN ZANDVOORT LJC, Otsuka K, Villiger M, Neleman T, et al
    Polarimetric Signatures of Coronary Thrombus in Patients With Acute Coronary Syndrome.
    Circ J. 2021;85:1806-1813.
    PubMed         Abstract available

  71. INAGAKI Y, Arashi H, Yamaguchi J, Ogawa H, et al
    Greater Change in the Eicosapentaenoic Acid to Arachidonic Acid Ratio Is Associated With Decreased Incidence of Cardiovascular Events in Acute Coronary Syndrome Patients With Elevated Triglyceride Levels.
    Circ J. 2021;85:1746-1753.
    PubMed         Abstract available

  72. SHIBATA N, Umemoto N, Tanaka A, Takagi K, et al
    Clinical Outcomes Following Emergent Percutaneous Coronary Intervention for Acute Total/Subtotal Occlusion of the Left Main Coronary Artery.
    Circ J. 2021;85:1789-1796.
    PubMed         Abstract available

  73. KHALIFA AKM, Kubo T, Shimamura K, Ino Y, et al
    Impact of Optical Coherence Tomography Imaging on Decision-Making During Percutaneous Coronary Intervention in Patients Presented With Acute Coronary Syndromes.
    Circ J. 2021;85:1781-1788.
    PubMed         Abstract available

    Circ Res

  74. YOUNG A, Bradley LA, Farrar E, Bilcheck HO, et al
    Inhibition of DYRK 1a Enhances Cardiomyocyte Cycling After Myocardial Infarction.
    Circ Res. 2022 Apr 4:101161CIRCRESAHA121320005.
    PubMed         Abstract available


  75. SINGH T, Khan H, Gamble DT, Scally C, et al
    Takotsubo Syndrome: Pathophysiology, Emerging Concepts, and Clinical Implications.
    Circulation. 2022;145:1002-1019.
    PubMed         Abstract available

    Eur Heart J

  76. ROMAGUERA R, Salinas P, Gomez-Lara J, Brugaletta S, et al
    Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial.
    Eur Heart J. 2022;43:1320-1330.
    PubMed         Abstract available

  77. DAVIERWALA PM, Gao C, Thuijs DJFM, Wang R, et al
    Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
    Eur Heart J. 2021 Aug 18. pii: 6354120. doi: 10.1093.
    PubMed         Abstract available

  78. BUCCIARELLI-DUCCI C, Ajmone-Marsan N, Di Carli M, Nicol E, et al
    The year in cardiovascular medicine 2021: imaging.
    Eur Heart J. 2022;43:1288-1295.
    PubMed         Abstract available

  79. BYRNE RA, Rai H, Colleran R
    Amphilimus-eluting stents in coronary artery disease: finally, a sweet spot for patients with diabetes mellitus?
    Eur Heart J. 2022;43:1331-1333.

  80. BANNING AP, Serruys P, De Maria GL, Ryan N, et al
    Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study.
    Eur Heart J. 2021 Oct 7. pii: 6383065. doi: 10.1093.
    PubMed         Abstract available

  81. HAN Y
    Chinese expert consensus statement on dual antiplatelet therapy in patients with coronary artery disease.
    Eur Heart J. 2022;43:1283-1285.

  82. CHIKWE J, Alfieri OR
    The optimal strategy for multivessel coronary revascularization.
    Eur Heart J. 2021 Nov 11. pii: 6425621. doi: 10.1093.

  83. SAMMONS E, Hopewell JC, Chen F, Stevens W, et al
    Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
    Eur Heart J. 2022;43:1416-1424.
    PubMed         Abstract available


  84. PARCHA V, Pampana A, Bress AP, Irvin MR, et al
    Association of Polygenic Risk Score With Blood Pressure and Adverse Cardiovascular Outcomes in Individuals With Type II Diabetes: Insights From the ACCORD Trial.
    Hypertension. 2022 Apr 4:HYPERTENSIONAHA12218976.

    Int J Cardiol

  85. LI Q, Li Z, Li T, Liu C, et al
    Involvement of the crosstalk between Nrf2 and NF-kappaB pathways regulated by SIRT1 in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2022;355:44.

  86. TSUGU T, Tanaka K, Belsack D, Devos H, et al
    Effects of left ventricular mass on computed tomography derived fractional flow reserve in significant obstructive coronary artery disease.
    Int J Cardiol. 2022;355:59-64.
    PubMed         Abstract available

  87. HOLZKNECHT M, Reinstadler SJ
    CRP: a potential target in reperfused STEMI? Reply to the letter: "Targeting CRP in microvascular obstruction after PCI".
    Int J Cardiol. 2022;355:5.

  88. DIEU X, Chabrun F, Prunier F, Angoulvant D, et al
    Post-infarct cardiac remodeling predictions with machine learning.
    Int J Cardiol. 2022;355:1-4.
    PubMed         Abstract available

  89. BOTTO GL, Mantovani LG, Cortesi PA, De Ponti R, et al
    The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00483.
    PubMed         Abstract available

    J Am Coll Cardiol

  90. MENSAH GA, Fuster V
    Sex and Gender Differences in Cardiovascular Health.
    J Am Coll Cardiol. 2022;79:1385-1387.

  91. CLAYTON JA, Gaugh MD
    Sex as a Biological Variable in Cardiovascular Diseases: JACC Focus Seminar 1/7.
    J Am Coll Cardiol. 2022;79:1388-1397.
    PubMed         Abstract available

  92. GAUDINO M, Di Franco A, Cao D, Giustino G, et al
    Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7.
    J Am Coll Cardiol. 2022;79:1407-1425.
    PubMed         Abstract available

  93. GRANDIN EW, Nunez JI, Willar B, Kennedy K, et al
    Mechanical Left Ventricular Unloading in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation.
    J Am Coll Cardiol. 2022;79:1239-1250.
    PubMed         Abstract available

  94. MEHRAN R, Cao D, Vogel B
    Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG.
    J Am Coll Cardiol. 2022;79:1285-1287.

  95. SOLOLA NUSSBAUM S, Henry S, Yong CM, Daugherty SL, et al
    Sex-Specific Considerations in the Presentation, Diagnosis, and Management of Ischemic Heart Disease: JACC Focus Seminar 2/7.
    J Am Coll Cardiol. 2022;79:1398-1406.
    PubMed         Abstract available

    J Cardiovasc Pharmacol

  96. AKYILDIZ AG, Biondi-Zoccai G, De Biase D
    Impact of the Gastrointestinal Tract Microbiota on Cardiovascular Health and Pathophysiology.
    J Cardiovasc Pharmacol. 2022 Apr 6. pii: 00005344-990000000-00021.
    PubMed         Abstract available

  97. DAI H, Zhao N, Zheng Y
    CircLDLR modulates the proliferation and apoptosis of vascular smooth muscle cells in coronary artery disease through miR-26-5p/KDM6A axis.
    J Cardiovasc Pharmacol. 2022 Apr 6. pii: 00005344-990000000-00018.
    PubMed         Abstract available

  98. ADEVA-ANDANY MM, Fernandez-Fernandez C, Carneiro-Freire N, Castro-Quintela E, et al
    Cardiovascular protection associated with cilostazol, colchicine and target of rapamycin inhibitors.
    J Cardiovasc Pharmacol. 2022 Apr 6. pii: 00005344-990000000-00019.
    PubMed         Abstract available

  99. LIU X, Qi K, Gong Y, Long X, et al
    Ferulic Acid Alleviates Myocardial Ischemia Reperfusion Injury Via Upregulating AMPKalpha2 Expression-Mediated Ferroptosis Depression.
    J Cardiovasc Pharmacol. 2021;79:489-500.
    PubMed         Abstract available

  100. DENG X, Liu Y, Xu Z, Wang Z, et al
    lncRNA Nuclear Factor of Activated T Cells Knockdown Alleviates Hypoxia/Reoxygenation-induced Cardiomyocyte Apoptosis by Upregulating HIF-1alpha Expression.
    J Cardiovasc Pharmacol. 2022;79:479-488.
    PubMed         Abstract available

  101. VLACHAKIS PK, Varlamos C, Benetou DR, Kanakakis I, et al
    Periprocedural Antithrombotic Treatment in Complex Percutaneous Coronary Intervention.
    J Cardiovasc Pharmacol. 2022;79:407-419.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  102. DENG X, Zhang C, Wang P, Wei W, et al
    Cardiovascular benefits of empagliflozin are associated with gut microbiota and plasma metabolites in type 2 diabetes.
    J Clin Endocrinol Metab. 2022 Apr 9. pii: 6565990. doi: 10.1210.
    PubMed         Abstract available

    J Clin Epidemiol

  103. TERVONEN T, Prawitz T, Chua GN, Hyacinthe J, et al
    Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment.
    J Clin Epidemiol. 2022;144:84-92.
    PubMed         Abstract available

    J Mol Cell Cardiol

  104. KONG D, Yu Y
    Prostaglandin D2 signaling and cardiovascular homeostasis.
    J Mol Cell Cardiol. 2022;167:97-105.
    PubMed         Abstract available


  105. RABER L, Ueki Y, Otsuka T, Losdat S, et al
    Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
    JAMA. 2022 Apr 3. pii: 2790913. doi: 10.1001/jama.2022.5218.
    PubMed         Abstract available


  106. BERGMARK BA, Mathenge N, Merlini PA, Lawrence-Wright MB, et al
    Acute coronary syndromes.
    Lancet. 2022;399:1347-1358.
    PubMed         Abstract available

    N Engl J Med

    Childhood Risk Factors and Prediction of Adult Cardiovascular End Points.
    N Engl J Med. 2022 Apr 4. doi: 10.1056/NEJMe2203743.

  108. JACOBS DR JR, Woo JG, Sinaiko AR, Daniels SR, et al
    Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022 Apr 4. doi: 10.1056/NEJMoa2109191.
    PubMed         Abstract available

    Psychosom Med

  109. DASA O, Mahmoud AN, Kaufmann PG, Ketterer M, et al
    Relationship of Psychological Characteristics to Daily Life Ischemia: An Analysis From the National Heart, Lung, and Blood Institute Psychophysiological Investigations in Myocardial Ischemia.
    Psychosom Med. 2022;84:359-367.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.